CIK 0001768224 · Accelerated filer<br>Smaller reporting company
Arcturus Therapeutics Holdings Inc.
Sign in to watch- Ticker
- ARCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 8589002660
- Business address
- 10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $18.72 ($93,602)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $25.61 ($128,062)
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Other events
- 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $31.45 ($157,264)
- 144 Insider Sale of Securities
- 4 Grant or award Chief Financial Officer acquired 1,223 shares (grant or award)
- 8-K Event Material agreement · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 424B5 Offering Prospectus
- 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $34.91 ($174,550)
Page 7 of 21 · 416 filings